CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker. Hu H, Xiang Y, Zhang XY, Deng Y, et al. Oncol Rep 2022;48.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hu H, Xiang Y, Zhang XY, Deng Y, et al. CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker. Oncol Rep 2022;48.
PMID: 36004470